Over a multi-week protocol, this systematic underdosing compounds, potentially invalidating research outcomes
Not all rheumatologists will be comfortable with this addition to your regimen, and their concerns should be taken seriously
Serious but less common risks include pancreatitis, gallbladder disease, low blood sugar (particularly if used with diabetes medications), and kidney problems
Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimers disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial
For any health related concerns, please consult with your physician, or call 911
What is the difference between tirzepatide and retatrutide